XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 4 - Fair Value of Financial Instruments
6 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

4. Fair Value of Financial Instruments

 

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, trade accounts and notes receivable and accounts payable. Due to the short-term maturities of cash and cash equivalents, trade accounts and notes receivable and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates.   The Company measures its short-term investments at fair value on a recurring basis.

 

The following tables present the fair value of the Company’s short-term investments and contingent consideration by valuation hierarchy and input (in thousands):

 

 

  

As of March 31, 2024

 
  

Quoted Prices in

  

Significant

         
  

Active Markets for

  

Other

  

Significant

     
  

Identical Assets

  

Observable

  

Unobservable

     
  

(Level 1)

  

(Level 2)

  

(Level 3)

  

Totals

 

Short-term investments:

                

Corporate bonds

 $  $21,923  $  $21,923 

U.S. treasury securities and securities of U.S. government-sponsored agency

      8,525       8,525 

Total assets

 $  $30,448  $  $30,448 

 

 

 

 

 

 

  

As of September 30, 2023

 
  

Quoted Prices in

  

Significant

         
  

Active Markets for

  

Other

  

Significant

     
  

Identical Assets

  

Observable

  

Unobservable

     
  

(Level 1)

  

(Level 2)

  

(Level 3)

  

Totals

 

Short-term investments:

                

Corporate bonds

 $  $11,295  $  $11,295 

U.S. treasury securities and securities of U.S. government-sponsored agency

     3,626      3,626 

Total assets

 $  $14,921  $  $14,921